Release Summary

Neurovance, developing novel therapeutic for ADHD, announces Brian Goff appointed Chief Operating Officer. Brings 25 years of leadership experience to the Co. Exec.Board Chair Jeff Bailey named CEO.

Neurovance, Inc.